5.0
9 Dec 2025
Recommend
CEO approval
Business outlook
Pros
Good compensations. Good reputation in Biotechs.
Cons
Scientist track and management track are separated in R&D. Limited opportinity to move from the scientist track to management track.
Engaged employer
Be the first to recommend this company
Ashley Magargee
Not enough data to show CEO approval
Check out your Company Bowl for anonymous work chats.